Castle Biosciences, Inc.

24.34 USD
+0.10 (+0.41%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Castle Biosciences, Inc. stock is up 26.05% since 30 days ago. The next earnings date is Jul 31, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 60% of the previous 4 May’s closed higher than April. In the last 2 Unusual Options Trades, there were 2 PUTs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
22 Mar 19:01 17 May, 2024 20.00 PUT 142 0
03 May 18:04 21 Jun, 2024 22.50 PUT 480 0

About Castle Biosciences, Inc.

Castle Biosciences, Inc. focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company was founded in 2007 and is headquartered in Friendswood, Texas.